OBJECTIVE：To provide applicable suggestions for exploring the establishement of the vaccination rare adverse reactions compensation fund in China. METHODS ：Through literature research and regulation review ， the establishment background，compensation principle ，management and operation mode （including management methods ，source，uses and risk control measures）of Vaccine Injury Compensation Trust Fund in the United States were introduced in details ，while the operation effect was evaluated ，and the suggestions for the establishment of the vaccination rare adverse reactions compensation fund in China were put forward. RESULTS & CONCLUSIONS ：The U.S. National Vaccine Injury Compensation Program （VICP）imposed a certain proportion of vaccine excise tax on each dose of vaccine sold by vaccine companies ，and established the Vaccine Injury Compensation T rust F und as its fixed source of compensation funds to provide compensation for vaccine victims. The fund belonged to the special needs trust. When the vaccine victims met the compensation conditions ，they can convert their compensation rights into the beneficial rights under the trust law. The fund was managed by the Fund Management Branch under U.S. Dept. of the Treasury，and it took a variety of risk control measures such as capital guaranteed investment ，subrogation，emergency preparedness. As of 2018，a large number of fund balances had been accumulated ，which was sufficient to ensure the solvency of VICP. It is suggested that China fully learn from the successful experience of the Vaccine Injury Compensation Trust Tund of the United States ， based on the domestic reality ，start from improving the relevant legislation of the compensation fund ，building the compensation management system ，making clear the source and usage of the fund ，taking various risk control measures ，so as to explore the establishment of China ’s vaccination rare adverse reactions compensation fund ，further expand the financing channels ，stabilize the source of funds ，and improve the compensation effect.